The European ​Medicines Agency's ‌committee on Friday ​recommended ​approval of Eli ⁠Lilly's weight-loss ​pill ​Foundayo, paving the way for ​a ​second oral weight-loss ‌drug ⁠to win backing in ​the ​region ⁠after Novo ​Nordisk's ​Wegovy ⁠pill.

Log in or sign up to comment.

No comments yet.

← Back to stories

Create FREE account

or login to continue

Signup with GoogleSignup with GitHubSignup with BlueskySignup with Blacksky
Sign up with email

Already have an account? Log in